Literature summary extracted from
Karlberg, T.; Collins, R.; van den Berg, S.; Flores, A.; Hammarstroem, M.; Hoegbom, M.; Holmberg Schiavone, L.; Uppenberg, J.
Structure of human argininosuccinate synthetase (2008), Acta Crystallogr. Sect. D, 64, 279-286.
Cloned(Commentary)
EC Number |
Cloned (Comment) |
Organism |
---|
6.3.4.5 |
expression of ASS1 |
Homo sapiens |
Crystallization (Commentary)
EC Number |
Crystallization (Comment) |
Organism |
---|
6.3.4.5 |
purified recombinant ASS1 by hanging-drop method, 0.001 ml of protein solution containing 17 mg/ml protein in 500 mM NaCl, 2 mM TCEP, 30 mM HEPES, pH 7.5, 10 mM aspartate, and 10 mM citrulline, is mixed with 0.001 ml of reservoir solution containing 16% w/v PEG 3350, 0.15 M dl-malic acid pH 7.0, X-ray diffraction structure determination and analysis at 2.4-2.5 A resolution |
Homo sapiens |
Protein Variants
EC Number |
Protein Variants |
Comment |
Organism |
---|
6.3.4.5 |
additional information |
clinical mutations, phenotypes, overview |
Homo sapiens |
Metals/Ions
EC Number |
Metals/Ions |
Comment |
Organism |
Structure |
---|
6.3.4.5 |
Mg2+ |
- |
Homo sapiens |
|
Natural Substrates/ Products (Substrates)
EC Number |
Natural Substrates |
Organism |
Comment (Nat. Sub.) |
Natural Products |
Comment (Nat. Pro.) |
Rev. |
Reac. |
---|
6.3.4.5 |
ATP + L-citrulline + L-aspartate |
Homo sapiens |
citrulline-aspartate ligase is the rate-limiting enzyme in the synthesis of the amino acid arginine. Type I citrullinaemia is a disorder caused by mutations in the ASS gene leading to reduced or abolished activity of the ASS enzyme |
AMP + diphosphate + 2-(Nomega-L-arginino)succinate |
- |
? |
|
6.3.4.5 |
additional information |
Homo sapiens |
in mammals, the urea-cycle enzymes ASS and argininosuccinatelyase are part of an additional pathway together with the enzyme nitric oxide synthase, forming the arginine-citrulline cycle |
? |
- |
? |
|
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
6.3.4.5 |
Homo sapiens |
P00966 |
ASS1 |
- |
Purification (Commentary)
EC Number |
Purification (Comment) |
Organism |
---|
6.3.4.5 |
recombinant ASS1 by His affinity chromatography and gel filtration |
Homo sapiens |
Substrates and Products (Substrate)
EC Number |
Substrates |
Comment Substrates |
Organism |
Products |
Comment (Products) |
Rev. |
Reac. |
---|
6.3.4.5 |
ATP + L-citrulline + L-aspartate |
citrulline-aspartate ligase is the rate-limiting enzyme in the synthesis of the amino acid arginine. Type I citrullinaemia is a disorder caused by mutations in the ASS gene leading to reduced or abolished activity of the ASS enzyme |
Homo sapiens |
AMP + diphosphate + 2-(Nomega-L-arginino)succinate |
- |
? |
|
6.3.4.5 |
ATP + L-citrulline + L-aspartate |
substrate binding structures, overview |
Homo sapiens |
AMP + diphosphate + 2-(Nomega-L-arginino)succinate |
- |
? |
|
6.3.4.5 |
additional information |
in mammals, the urea-cycle enzymes ASS and argininosuccinatelyase are part of an additional pathway together with the enzyme nitric oxide synthase, forming the arginine-citrulline cycle |
Homo sapiens |
? |
- |
? |
|
Subunits
EC Number |
Subunits |
Comment |
Organism |
---|
6.3.4.5 |
tetramer |
two dimers, dimeric and tetrameric interface structures, overview |
Homo sapiens |
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
6.3.4.5 |
Argininosuccinate synthetase |
- |
Homo sapiens |
6.3.4.5 |
ASS |
- |
Homo sapiens |
6.3.4.5 |
Citrulline-aspartate ligase |
- |
Homo sapiens |
Cofactor
EC Number |
Cofactor |
Comment |
Organism |
Structure |
---|
6.3.4.5 |
ATP |
binding structure, conformational change upon ATP binding |
Homo sapiens |
|